SANGAM PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: F84658 | LONDON, E12 5JF
Showing results 101-150 of 568
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Glyceryl trinitrate | 376 | 2,888 | £1.8K | +59.0% ▲ |
| Olanzapine | 357 | 6,881 | £799 | -3.6% ▼ |
| Docusate sodium | 352 | 21.2K | £1.5K | -5.1% ▼ |
| Ivabradine | 345 | 8,736 | £2.1K | +262.9% ▲ |
| 345 | 42.9K | £1.3K | +24.8% ▲ | |
| Hydroxychloroquine sulfate | 343 | 11.5K | £649 | +77.1% ▲ |
| Carbamazepine | 340 | 42.1K | £2.5K | +14.6% ▲ |
| Enalapril maleate | 337 | 6,111 | £280 | +87.6% ▲ |
| Nicorandil | 330 | 13.2K | £2.2K | +129.2% ▲ |
| Nitrofurantoin | 326 | 4,008 | £2.0K | -31.7% ▼ |
| Pravastatin sodium | 320 | 5,831 | £285 | -1.5% vs avg |
| Felodipine | 318 | 4,622 | £789 | -46.5% ▼ |
| Loratadine | 318 | 17.8K | £466 | +52.2% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 309 | 1.3M | £14.6K | +606.3% ▲ |
| Coal tar | 307 | 78.7K | £1.7K | +321.7% ▲ |
| Ranolazine | 306 | 9,782 | £1.8K | +80.1% ▲ |
| Venlafaxine | 298 | 9,567 | £2.0K | -64.7% ▼ |
| 298 | 588 | £21.0K | -45.3% ▼ | |
| Mometasone furoate | 295 | 322 | £2.5K | -26.5% ▼ |
| Mometasone furoate | 293 | 19.5K | £1.8K | +119.1% ▲ |
| Buprenorphine | 292 | 1,267 | £3.7K | -20.3% ▼ |
| Esomeprazole | 290 | 7,770 | £669 | -28.3% ▼ |
| Aripiprazole | 288 | 14.6K | £3.2K | +13.2% ▲ |
| Sodium valproate | 287 | 21.2K | £4.2K | -9.8% ▼ |
| Carbomer 940/980 | 287 | 3,610 | £829 | +88.5% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 284 | 13.8K | £982 | +25.7% ▲ |
| Warfarin sodium | 283 | 9,408 | £338 | -40.0% ▼ |
| Dapagliflozin/metformin | 282 | 10.4K | £6.5K | +542.1% ▲ |
| Doxycycline hyclate | 278 | 4,440 | £433 | -45.8% ▼ |
| Methotrexate | 278 | 5,706 | £1.5K | -14.6% ▼ |
| Calcipotriol | 277 | 22.7K | £13.4K | +62.7% ▲ |
| Sacubitril/valsartan | 270 | 10.8K | £17.6K | +12.8% ▲ |
| Betamethasone esters | 267 | 20.5K | £2.4K | +342.6% ▲ |
| Ketoconazole | 266 | 38.6K | £6.9K | +170.9% ▲ |
| Flucloxacillin sodium | 264 | 10.6K | £547 | -41.3% ▼ |
| Semaglutide | 264 | 3,047 | £21.9K | +9.6% ▲ |
| Duloxetine hydrochloride | 260 | 5,894 | £398 | -59.1% ▼ |
| Fenofibrate | 258 | 5,677 | £641 | +166.6% ▲ |
| Typhoid | 249 | 249 | £2.6K | +176.5% ▲ |
| 249 | 264 | £1.6K | +5.4% ▲ | |
| Other multivitamin preparations | 245 | 5,249 | £946 | +41.8% ▲ |
| Quetiapine | 240 | 9,783 | £2.8K | -61.5% ▼ |
| Chlorphenamine maleate | 238 | 24.8K | £678 | +115.6% ▲ |
| Betahistine hydrochloride | 235 | 16.0K | £567 | -1.6% vs avg |
| Mirabegron | 234 | 6,174 | £5.7K | -41.7% ▼ |
| Tacrolimus | 232 | 10.4K | £8.1K | +330.2% ▲ |
| Sodium cromoglicate | 231 | 3,223 | £899 | +148.7% ▲ |
| Nifedipine | 227 | 6,722 | £1.7K | +21.1% ▲ |
| Tiotropium bromide | 226 | 4,547 | £5.5K | -25.7% ▼ |
| Biphasic insulin lispro | 226 | 1,484 | £9.2K | +426.4% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.